{
  "ticker": "GIV",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02961149",
  "id": "02961149",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250623",
  "time": "1739",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250623/pdf/06l0sjmd3727kv.pdf",
  "summary": "- **Fund Performance (as of 31 May 2025):**  \n  - 1-year return: **2.67%** (vs. benchmark 4.20%); 3-year p.a.: **10.29%** (vs. benchmark 9.34%).  \n  - Slight underperformance YTD but outperformance over 3 years (+0.96% p.a.).  \n\n- **Top Holdings (Concentrated Positions):**  \n  - **Overweights**: Deterra Royalties (5.8%), Reliance Worldwide (5.2%), EVT Ltd (5.2%).  \n  - **Underweights**: BHP Group, CBA, Wesfarmers (not held).  \n\n- **Key Portfolio Metrics:**  \n  - P/E: **18.3x** (vs. benchmark 18.8x); Dividend Yield: **3.2%** (vs. 3.5%).  \n  - Sector Exposure: Financials ex-Property (19.7%), Industrials (16.2%), Materials (15.8%).  \n\n- **Notable Stock Commentary:**  \n  - **EVT Ltd (+15.0%)**: Catalysts from cinema recovery and asset divestments.  \n  - **Ramsay Healthcare (+15.2%)**: Benefited from Healthscope\u2019s collapse; cost pressures remain.  \n  - **BlueScope (-4.7%)**: Trump\u2019s approval of US Steel-Nippon deal raised competition concerns.  \n\n- **Market Outlook:**  \n  - Concerns over US debt/deficits but equity resilience persists.  \n  - Potential inflection point in global capital flows amid shifting policies (US deregulation, Germany reflation).  \n\n**Omitted**: Routine ESG screens, distribution frequency, management fee.",
  "usage": {
    "prompt_tokens": 2931,
    "completion_tokens": 369,
    "total_tokens": 3300,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-23T07:59:55.610037"
}